The following 6 proteins were significantly associated with MMD at the genetic, genomic and antibodyomic level as outlined in Table 3: stimulated by retinoic acid 13 (STRA13), amyloid beta A4 protein (APP), catenin, beta 1 (CTNNB1), G protein pathway suppressor 1 (GPS1), receptor tyrosine kinase-like orphan receptor 1 (ROR1), and EGF-like repeats and discoidin I-like domains 3 (EDIL3). Here, ROR1 is linked to multiminicore myopathy.